Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Clinical trial NCT03118739 · COMPLETED

Trial details

NCT number: NCT03118739
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperuricemia Albuminuria Type 2 Diabetes

Start date: 2017-05-18
Primary completion: 2018-08-13
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.